Skip to main content

Breast Cancer

Edited by: Dr Marc Lippman

The Breast Cancer Collection is an invitation-only sister title of the Springer subscription journal, Breast Cancer Research and Treatment (BREA).

Invited submissions should choose the Breast Cancer Collection during submission, and include the invitation letter from Dr Lippman in their SpringerPlus cover letter.

For more information about how you can be considered for the Breast Cancer Collection, please speak to the editorial team at BREA.

 

Collection Articles:

Page 1 of 4

  1. We describe impairments after breast cancer and its treatment for African American (AA), non-Hispanic white and low-income breast cancer survivors (BCS) and whether physical therapy (PT) was utilized to addres...

    Authors: Ann Marie Flores, Jason Nelson, Lee Sowles, Karen Bienenstock and William J. Blot
    Citation: SpringerPlus 2016 5:1227
  2. New treatments with novel mechanisms of action and non-overlapping toxicities are needed for patients with metastatic breast cancer. Etirinotecan pegol (EP) is a long-acting topoisomerase-I inhibitor with a un...

    Authors: Javier Cortés, Hope S. Rugo, Chris Twelves, Ahmad Awada, Edith A. Perez, Seock-Ah Im, Carol Zhao, Ute Hoch, Denise Tomkinson, James Buchanan, Mary Tagliaferri, Alison Hannah and Joyce O’Shaughnessy
    Citation: SpringerPlus 2016 5:1033
  3. To determine frequency of routine radiological staging of breast cancer patients diagnosed in a German Breast Cancer Screening Center from 2007 to 2014, the incidence and consequences of distant metastases det...

    Authors: Peter Rusch, Oliver Hoffmann, Anna-L. Stickelmann, Stephan Böhmer, Regine Gätje, Karl G. Krüger, Stefan Niesert, Andrea Schmidt and Rainer Kimmig
    Citation: SpringerPlus 2016 5:1010
  4. This study aimed to compare the efficacy and safety of the newest bipolar vessel sealing system (BVSS; LigaSureâ„¢ Small Jaw) to that of conventional technique in axillary dissection.

    Authors: Tomoko Seki, Tetsu Hayashida, Maiko Takahashi, Hiromitsu Jinno and Yuko Kitagawa
    Citation: SpringerPlus 2016 5:1004
  5. Breast reconstruction after mastectomy is an integral part of breast cancer treatment that positively impacts quality of life in breast cancer survivors. Although breast reconstruction rates have increased ove...

    Authors: Shahnjayla K. Connors, Melody S. Goodman, Terence Myckatyn, Julie Margenthaler and Sarah Gehlert
    Citation: SpringerPlus 2016 5:955
  6. Glucocorticoid receptor (GR) overexpression is associated with poor prognosis ER-negative breast cancer. GR antagonism with mifepristone increases chemotherapy-induced breast cancer cell death, therefore we co...

    Authors: Rita Nanda, Erica M. Stringer-Reasor, Poornima Saha, Masha Kocherginsky, Jean Gibson, Bernadette Libao, Philip C. Hoffman, Elias Obeid, Douglas E. Merkel, Galina Khramtsova, Maxwell Skor, Thomas Krausz, Ronald N. Cohen, Mark J. Ratain, Gini F. Fleming and Suzanne D. Conzen
    Citation: SpringerPlus 2016 5:947
  7. P38 mitogen-activated protein kinases (MAPK) level is an important prognostic factor in breast cancer. This study was performed to detect the expressions of P-p38 MAPK expression in breast cancer and explore t...

    Authors: Bin Wang, Huayong Jiang, Ning Ma and Yajie Wang
    Citation: SpringerPlus 2016 5:934
  8. We have evaluated thoracic conformation of patients in order to derive a numeric value predictive of an increased dose to left anterior descending coronary artery (LAD), critical structure for the development ...

    Authors: R. Di Franco, V. Ravo, V. Nieddu, A. Crispo, S. Falivene, F. M. Giugliano, A. Argenone, V. Borzillo, F. Cammarota and P. Muto
    Citation: SpringerPlus 2016 5:841
  9. To evaluate breast findings incidentally detected on body MRI.

    Authors: Bianca Bignotti, Giulia Succio, Francesca Nosenzo, Michela Perinetti, Licia Gristina, Stella Barbagallo, Lucia Secondini, Massimo Calabrese and Alberto Tagliafico
    Citation: SpringerPlus 2016 5:781
  10. Our study examines the impact of breast cancer-related lymphedema on women’s work and career. Our research addresses a significant knowledge gap regarding the additional impact of lymphedema on breast cancer s...

    Authors: John Boyages, Senia Kalfa, Ying Xu, Louise Koelmeyer, Helen Mackie, Hector Viveros, Lucy Taksa and Paul Gollan
    Citation: SpringerPlus 2016 5:657
  11. Luminal B breast tumors have aggressive clinical and biological features, and constitute the most heterogeneous molecular subtype, both clinically and molecularly. Unfortunately, the immunohistochemistry corre...

    Authors: Naiara G. Bediaga, Elena Beristain, Borja Calvo, María A. Viguri, Borja Gutierrez-Corres, Ricardo Rezola, Irune Ruiz-Diaz, Isabel Guerra and Marian M. de Pancorbo
    Citation: SpringerPlus 2016 5:623
  12. The aims of this study were to comprehensively describe the psychosocial and medical characteristics of women who initiated tamoxifen or aromatase inhibitors for breast cancer and to compare levels of emotiona...

    Authors: Ozturk Ates, Cem Soylu, Taner Babacan, Furkan Sarici, Neyran Kertmen, Deborah Allen, Ali Riza Sever and Kadri Altundag
    Citation: SpringerPlus 2016 5:486
  13. The purpose of this exploratory candidate gene association study was to examine relationships between polymorphisms in oxidative stress and DNA repair genes and pre-adjuvant therapy cognitive function (CF) in ...

    Authors: Theresa A. Koleck, Catherine M. Bender, Susan M. Sereika, Adam M. Brufsky, Barry C. Lembersky, Priscilla F. McAuliffe, Shannon L. Puhalla, Priya Rastogi and Yvette P. Conley
    Citation: SpringerPlus 2016 5:422
  14. Radial scar and radial sclerosis (RS) are considered benign breast lesions with proliferative features. There is sparse literature on frequency of cancer upgrade in these patients without atypical features fou...

    Authors: Elizabeth Min Hui Kim, Andrea Hankins, Jamie Cassity, Dennis McDonald, Barbara White, Ron Rowberry, Sharon Dutton and Claire Snyder
    Citation: SpringerPlus 2016 5:398
  15. The NSABP Trial B-31 and NCCTG Trial N9831 (B-31/N9831 trials, Romond et al. in N Engl J Med 353:1673–84, 2005. doi:10.​1056/​NEJMoa052122; Perez et al. ...

    Authors: Christopher M. Gallagher, Kenneth More, Anthony Masaquel, Tripthi Kamath, Annie Guerin, Raluca Ionescu-Ittu, Roy Nitulescu, Marjolaine Gauthier-Loiselle, Nicholas Sicignano, Elizabeth Butts, Eric Q. Wu and Brian Barnett
    Citation: SpringerPlus 2016 5:395
  16. Epidemiologic studies have associated obesity with increased risk of the aggressive basal-like breast cancer (BBC) subtype. Hepatocyte growth factor (HGF) signaling through its receptor, cMET, is elevated in o...

    Authors: Alyssa J. Cozzo, Sneha Sundaram, Ottavia Zattra, Yuanyuan Qin, Alex J. Freemerman, Luma Essaid, David B. Darr, Stephanie A. Montgomery, Kirk K. McNaughton, J. Ashley Ezzell, Joseph A. Galanko, Melissa A. Troester and Liza Makowski
    Citation: SpringerPlus 2016 5:348
  17. The treatment goals for metastatic breast cancer (MBC) are prolonging survival and improving the quality of life. Eribulin, a non-taxane tubulin inhibitor, demonstrated improved survival in previous studies an...

    Authors: Tsutomu Takashima, Shinya Tokunaga, Seika Tei, Shigehiko Nishimura, Hidemi Kawajiri, Shinichiro Kashiwagi, Shigehito Yamagata, Satoru Noda, Takeo Nishimori, Yoko Mizuyama, Takeshi Sunami, Kenji Tezuka, Katsumi Ikeda, Yoshinari Ogawa, Naoyoshi Onoda, Tetsuro Ishikawa…
    Citation: SpringerPlus 2016 5:164
  18. To determine the chest wall movement of each patient during deep inspiratory breath hold (DIBH) and expiratory breath hold (EBH) in postoperative breast cancer patients. Postoperative breast cancer patients wh...

    Authors: C. Lowanichkiattikul, M. Dhanachai, C. Sitathanee, S. Khachonkham and P. Khaothong
    Citation: SpringerPlus 2016 5:144
  19. Predicting the risk of sentinel lymph node (SLN) metastasis is important for clinical decision-making in the setting of early breast cancer (EBC). This study is aimed to identify tumor and patient characterist...

    Authors: Nicla La Verde, Elena Biagioli, Chiara Gerardi, Andrea Cordovana, Chiara Casiraghi, Irene Floriani, Elena Bernardin, Gabriella Farina, Serena Di Cosimo, Maria Chiara Dazzani and Giorgio Gherardi
    Citation: SpringerPlus 2016 5:114
  20. We undertake an analysis of ongoing BC targeted therapy trials registered to CT.gov to describe patterns of ongoing clinical research, highlight gaps in current research programs and identify ways of optimizin...

    Authors: Sofia Torres, Christine Simmons, Jean-François Boileau, Deanna McLeod, Ilidio Martins and Maureen Trudeau
    Citation: SpringerPlus 2016 5:109
  21. Traditionally, women with node-positive operable breast cancer have received complete axillary lymph node dissection (ALND), which is associated with significant morbidity, but recently less invasive alternat...

    Authors: Mia Schmidt-Hansen, Nathan Bromham, Elise Hasler and Malcolm W. Reed
    Citation: SpringerPlus 2016 5:85
  22. Asian and Pacific Islander (API) women in the United States (U.S.) are a heterogeneous group reported to have better prognosis after breast cancer (BC) compared to their Non-Hispanic White (NHW) counterparts. ...

    Authors: Pooja A. Solanki, Naomi Y. Ko, Dima M. Qato and Gregory S. Calip
    Citation: SpringerPlus 2016 5:82
  23. This retrospective multicenter analysis was aimed to evaluate clinical activity and tolerability of eribulin in pretreated metastatic breast cancer patients in clinical practice. Patients treated with eribulin...

    Authors: Ornella Garrone, Filippo Montemurro, Chiara Saggia, Nicla La Verde, Anna Maria Vandone, Mario Airoldi, Enrico De Conciliis, Michela Donadio, Francesco Lucio, Maria Antonia Polimeni, Maria Vittoria Oletti, Alice Giacobino and Marco Carlo Merlano
    Citation: SpringerPlus 2016 5:59
  24. Women with breast cancer are at increased risk of second malignancy (SM). However, the impact of race and the hormone receptor (HR) status of the primary breast tumor on risk of SM are not known. The purpose o...

    Authors: Nicholas Diab, Gary Clark, Lucy Langer, Yunfei Wang, Barbara Hamlington, Laura Brzeskiewicz, Joyce O’Shaughnessy, Sami Diab and Salma K. Jabbour
    Citation: SpringerPlus 2016 5:14
  25. The aim of this study is to compare the current state of lesion identification, the BI-RADS classification and the contrast-enhancement behavior at 7T and 3T breast MRI in the same patient group. Twenty-seven ...

    Authors: Gisela L. G. Menezes, Bertine L. Stehouwer, Dennis W. J. Klomp, Tijl A. van der Velden, Maurice A. A. J. van den Bosch, Floortje M. Knuttel, Vincent O. Boer, Wybe J. M. van der Kemp, Peter R. Luijten and Wouter B. Veldhuis
    Citation: SpringerPlus 2016 5:13

    The Erratum to this article has been published in SpringerPlus 2016 5:1012

  26. Recent investigations have highlighted that therapeutic artificial microRNAs could be promising candidates for cancer therapy through the modulation of tumor promoter or suppressor. MEK kinase 1 (MEKK1) is exp...

    Authors: Chun Liu, Shengjie Wang, Shunxing Zhu, Haifeng Wang, Jiayi Gu, Zeping Gui, Jin Jing, Xiaofan Hou and Yixiang Shao
    Citation: SpringerPlus 2016 5:11
  27. Several reproductive factors are known to be associated with risk of breast cancer; however, relationships between these factors with risk of second primary asynchronous contralateral breast cancer (CBC) have ...

    Authors: Julia S. Sisti, Jonine L. Bernstein, Charles F. Lynch, Anne S. Reiner, Lene Mellemkjaer, Jennifer D. Brooks, Julia A. Knight, Leslie Bernstein, Kathleen E. Malone, Meghan Woods, Xiaolin Liang and Esther M. John
    Citation: SpringerPlus 2015 4:825
  28. A Breast Cancer Outcomes model was developed at the ONCOTYROL research center to evaluate personalized test-treatment strategies in Austria. The goal was to evaluate the cost-effectiveness of a new 21-gene ass...

    Authors: B. Jahn, U. Rochau, C. Kurzthaler, M. Hubalek, R. Miksad, G. Sroczynski, M. Paulden, M. Kluibenschädl, M. Krahn and U. Siebert
    Citation: SpringerPlus 2015 4:752
  29. Breast cancer risk increases transiently in the period following pregnancy; pregnancy-associated breast cancers (PABC) are more aggressive than cases diagnosed in nulliparous women. We have previously reported...

    Authors: Szilard Asztalos, Thao N. Pham, Peter H. Gann, Meghan K. Hayes, Ryan Deaton, Elizabeth L. Wiley, Rajyasree Emmadi, Andre Kajdacsy-Balla, Nilanjana Banerji, William McDonald, Seema A. Khan and Debra A. Tonetti
    Citation: SpringerPlus 2015 4:710
  30. Acquired or de novo resistance to the selective estrogen receptor modulators tamoxifen and fulvestrant (ICI) is a major barrier to successful treatment of breast cancer. Gene expression patterns in tamoxifen r...

    Authors: William Walter, Jennifer Thomalla, Josh Bruhn, Dedra H. Fagan, Cheryl Zehowski, Douglas Yee and Andrew Skildum
    Citation: SpringerPlus 2015 4:689
  31. Peritoneal metastasis from breast cancer is a serious and deadly condition only limited considered in the literature. Our aim was to study prevalence, risk factors, and prognosis of breast cancer peritoneal m...

    Authors: Serena Bertozzi, Ambrogio P. Londero, Carla Cedolini, Alessandro Uzzau, Luca Seriau, Sergio Bernardi, Stefano Bacchetti, Enrico Maria Pasqual and Andrea Risaliti
    Citation: SpringerPlus 2015 4:688
  32. Recent reports have suggested that women undergoing mastectomy, instead of wide local excision (WLE) for Stage I and II breast cancers have poorer overall survival. This is particularly important in our settin...

    Authors: Patrick M. Y. Chan, Bok Ai Choo, Tianjiao Zhang, Melanie D. W. Seah, Juliana J. C. Chen, Sarah Q. H. Lu and Ern Yu Tan
    Citation: SpringerPlus 2015 4:685
  33. Sentinel lymph node biopsy (SLNB) is the current standard of care for breast cancers with no clinically palpable axillary lymph nodes. Almost 50 % of sentinel lymph node positive patients have negative non-sen...

    Authors: Ramazan Yıldız, Murat Urkan, Oğuz Hancerliogulları, Zafer Kılbaş, Erkan Ozturk, Mustafa Oner Mentes and Semih Gorgulu
    Citation: SpringerPlus 2015 4:651
  34. The aim of the present study was to investigate the promoter methylation status of TRIM9 in breast cancer and to determine the presence of TRIM9-methylated circulating tumor DNA (ctDNA) in plasma. Bisulfite sequ...

    Authors: Chieko Mishima, Naofumi Kagara, Saki Matsui, Tomonori Tanei, Yasuto Naoi, Masafumi Shimoda, Atsushi Shimomura, Kenzo Shimazu, Seung Jin Kim and Shinzaburo Noguchi
    Citation: SpringerPlus 2015 4:635
  35. Despite being routinely prescribed worldwide for several years, data regarding the safety, efficacy, and survival benefit of eribulin in clinical settings for the treatment of metastatic breast cancer (MBC) ar...

    Authors: Junichiro Watanabe
    Citation: SpringerPlus 2015 4:625
  36. Less developed countries (LDCs) are struggling with an increasing burden of breast cancer. It is important to identify what interventions might be most effective and feasible in reducing overall breast cancer ...

    Authors: JunJie Li and ZhiMin Shao
    Citation: SpringerPlus 2015 4:615
  37. Eribulin mesylate has efficacy in patients who have received ≥2 prior chemotherapies for metastatic breast cancer (MBC) including an anthracycline and taxane. Phase 2 trials showed clinical activity and accept...

    Authors: Joyce O’Shaughnessy, Kristi McIntyre, Lee Schwartzberg, Sharon Wilks, Shannon Puhalla, Erhan Berrak, James Song and Linda Vahdat
    Citation: SpringerPlus 2015 4:532
  38. Angiogenesis is a key factor of tumor progression. Considering, that the tumor vessels are heterogeneous and differ in morphology and clinical significance, the purpose of this research was to study of the mor...

    Authors: Marina A. Senchukova, Natalia V. Nikitenko, Olesia N. Tomchuk, Nikon V. Zaitsev and Alexander A. Stadnikov
    Citation: SpringerPlus 2015 4:512
  39. Breast cancer is the most common type of cancer in women. The 5-year survival rate in patients with breast cancer ranges from 74 to 82 %. Sentinel lymph node biopsy has become an alternative to axillary lymph ...

    Authors: Fumihiko Matsuzawa, Kiyoka Omoto, Takahiro Einama, Hironori Abe, Takashi Suzuki, Jun Hamaguchi, Terumi Kaga, Mami Sato, Masako Oomura, Yumiko Takata, Ayako Fujibe, Chie Takeda, Etsuya Tamura, Akinobu Taketomi and Kenichi Kyuno
    Citation: SpringerPlus 2015 4:509
  40. Sentinel lymph nodes are mapped using 99mTechnetium, injected on day of surgery (1-day protocol) or day before (2-day protocol). This retrospective cohort study compares efficacy between the two protocols. Histop...

    Authors: Nazera Dodia, Deena El-Sharief and Cliona C. Kirwan
    Citation: SpringerPlus 2015 4:495
  41. The accumulation of wound fluid known as seroma in the chest cavity following breast surgery is a common occurrence that can persist for many weeks. While the pro-inflammatory composition of seroma is well est...

    Authors: Amanda Valeta-Magara, Raheleh Hatami, Deborah Axelrod, Daniel F. Roses, Amber Guth, Silvia C. Formenti and Robert J. Schneider
    Citation: SpringerPlus 2015 4:483